LEADER 04519nam 22006495 450 001 9910584477603321 005 20251204110258.0 010 $a3-030-98764-7 024 7 $a10.1007/978-3-030-98764-0 035 $a(MiAaPQ)EBC7045458 035 $a(Au-PeEL)EBL7045458 035 $a(CKB)24266133100041 035 $a(PPN)26389892X 035 $a(BIP)85097610 035 $a(BIP)83295949 035 $a(DE-He213)978-3-030-98764-0 035 $a(EXLCZ)9924266133100041 100 $a20220714d2022 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aLife Science Management $ePerspectives, Concepts and Strategies /$fedited by Avo Schönbohm, Hans Henning von Horsten, Philipp Plugmann 205 $a1st ed. 2022. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2022. 215 $a1 online resource (237 pages) 225 1 $aManagement for Professionals,$x2192-810X 311 08$aPrint version: Schönbohm, Avo Life Science Management Cham : Springer International Publishing AG,c2022 9783030987633 320 $aIncludes bibliographical references. 327 $aPart 1. Markets & Strategies -- Chapter 1. Development of the Life Sciences Industry Over the Past 30 Years -- Chapter 2. Venture Capital Perspectives on Life Science Innovation -- Chapter 3. Implications of Precision Medicine on Marketing & Sales Strategies -- Chapter 4. Intellectual Property in the Life Science Field - With a Focus on Patents -- Part 2. Technology & Data -- Chapter 5. How Ai Can Help Avoid Catastrophic Overload of Healthcare System in Times of a World-wide Pandemic -- Chapter 6. Event-driven Architecture for a Medical Records System -- Chapter 7. Hospitals of the Future ? How Can We Get There? -- Part 3. Change & Innovation -- Chapter 8. Life Science Management as a Multi-disciplinary Challenge in Global Innovation Competition -- Chapter 9. Trust and Incentives in Driving a Collaborative Innovation ? South Korean Life Science Industry -- Chapter 10. Drivers for Changes in the Evidence Generating Network for Biopharmaceuticals ? the Impact of the Covid-pandemic -- Chapter 11. OpenInnovation in the Life Science Industry -- Part 4. Leaders & Entrepreneurs -- Chapter 12. Ludic Leadership: the Counter-intuitive Case for Playing Games in the Life Science Industry -- Chapter 13. Learning to Lead ? a Non-profit Organization Perspective -- Chapter 14. Setting Up a Company in the Life Science Sector. 330 $aThe COVID-19 pandemic has reminded us of how important the life science industry is, and compels us to find efficient management methods specific to the industry. Pharmaceuticals, drug and vaccine development labs, R&D labs, medical instrumentation, and tech companies, hygiene supply companies, medical distribution chains, all form an integral part of this industry. At the interface of scientific research, technology, innovation and management and embedded in regulatory and legal frameworks, life science management is still an under-researched field of practice and science. This edited volume addresses this research gap and offers a wide range of practical and theoretical contributions that provide insights into one of the most exciting industries. The book is primarily directed at practitioners and decision makers in the life science industry. Students and professionals of life science management at all levels as well as policy makers will find valuable insights and inspiration for their daily work and career development. 410 0$aManagement for Professionals,$x2192-810X 606 $aHealth services administration 606 $aTechnological innovations 606 $aMedical economics 606 $aHealth Care Management 606 $aInnovation and Technology Management 606 $aHealth Economics 615 0$aHealth services administration. 615 0$aTechnological innovations. 615 0$aMedical economics. 615 14$aHealth Care Management. 615 24$aInnovation and Technology Management. 615 24$aHealth Economics. 676 $a362.1068 676 $a570.72 702 $aHorsten$b Hans Henning von 702 $aPlugmann$b Philipp$f1970- 702 $aScho?nbohm$b Avo 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910584477603321 996 $aLife science management$92999275 997 $aUNINA